Stem Cell Manufacturing Market Segmentation by End-Users (Hospitals & Surgical Centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institute, and Others); by Product (Consumables, Stem Cell Lines, and Instruments); and by Application (Research Application, Cell & Tissue Banking, and Clinical Application)-Global Demand Analysis & Opportunity Outlook 2031
-
Product Code:
RP-ID-10085610 -
Published Date:
25 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Stem Cell Manufacturing Market Highlights Over 2022 - 2031
The global stem cell manufacturing market is estimated to grow at a CAGR of ~9% over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a revenue of approximately USD 10.0 billion in 2021. The growth of the market can be attributed to the growing awareness for biologics and an increase in research to find out the best drug for the treatment of diseases. In addition, there has been a surge in neurological disorders across the globe for the treatment of which focus has been made on cells and tissues. Furthermore, according to the World Health Organization, hundreds of millions of people across the globe are affected by neurological disorders. Moreover, more than 6 million people die each year owing to strokes. Therefore, researchers are experimenting with stem cells to discover personalized medicines which are expected to increase the growth of the global stem cell manufacturing market.
GET A SAMPLE COPY OF THIS REPORT
The global stem cell manufacturing market is segmented by end-users into hospitals & surgical centers, pharmaceutical & biotechnology companies, research & academic institute, and others. Out of these, the pharmaceutical & biotechnology companies segment is expected to hold the largest share over the forecast period in the global stem cell manufacturing market owing to their growing focus on strategies for expanding their research in stem cells in order to stay ahead of other competitors.
Global Stem Cell Manufacturing Market Regional Synopsis
Regionally, the global stem cell manufacturing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. On the strength of the high prevalence of chronic diseases, advanced healthcare infrastructure, and an increase in research activities, the market in the North America region is anticipated to hold the largest over the forecast period. The market in the Asia Pacific region is estimated to witness modest growth over the forecast period on the back of an increase in the adoption of advanced technology and a surge in healthcare expenditure. Moreover, as per the World Bank, China’s health expenditure has increased from 4.51 percent of the GDP in 2000 to 5.35 percent of the GDP in 2019.
Market Segmentation
Our in-depth analysis of the global stem cell manufacturing market includes the following segments:
By End-Users
-
Hospitals & Surgical Centers
-
Pharmaceutical & Biotechnology Companies
-
Research & Academic Institute
-
Others
By Product
-
Consumables
-
Stem Cell Lines
-
Instruments
By Application
-
Research Application
-
Cell & Tissue Banking
-
Clinical Application
Growth Drivers and Challenges Impacting the Growth of the Global Stem Cell Manufacturing Market
Growth Drivers
-
Growing awareness of biologics
-
Surge in the prevalence of neurological disorders
Challenges
-
Lack of professionals for the use of stem cell
-
High cost of stem cell manufacturing
Key Companies Dominating the Global Stem Cell Manufacturing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global stem cell manufacturing market that are included in our report are Merck KGaA, Vericel Corporation, VistaGen Therapeutics, Inc., Catalent, Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., Bristol Myers Squibb Company, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, and others.
Latest Developments in the Global Stem Cell Manufacturing Market:
-
19 April 2022: Applied Cells Inc. and STEMCELL Technologies Canada Inc. announced a partnership to develop a new high-performance cell separation solution that combines Applied Cells' MARS platform and STEMCELL's EasySep immunomagnetic cell separation kits.
-
27 May 2020: VistaGen Therapeutics, Inc., announced its agreement with Nuformix to develop new crystalline forms of AV-101 for the treatment of multiple CNS conditions.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Growing awareness of biologics and surge in the neurological disorders are the major factors driving the growth of the stem cell manufacturing market.
The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2022-2031.
Lack of professionals for the use of stem cell and high cost of stem cell manufacturing are estimated to hamper the market growth.
Asia Pacific region will provide more business opportunities for growth of stem cell manufacturing market in future.
The major players in the market are Merck KGaA, Vericel Corporation, VistaGen Therapeutics, Inc., Catalent, Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., Bristol Myers Squibb Company, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by end-users, product, application, and by region.
The pharmaceutical & biotechnology companies segment is anticipated to hold largest market size in value over the forecast period and display significant growth opportunities.
Please enter your personal details below
- Merck KGaA
- Vericel Corporation
- VistaGen Therapeutics Inc.
- Catalent Inc.
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- Bristol Myers Squibb Company
- Bio-Rad Laboratories Inc.
- Becton Dickinson and Company